Literature DB >> 11944756

Reporting the clinical importance of randomized controlled trials.

David Moher, Douglas G Altman, Kenneth F Schulz.   

Abstract

Mesh:

Year:  2002        PMID: 11944756      PMCID: PMC99447     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

Review 1.  The revised CONSORT statement for reporting randomized trials: explanation and elaboration.

Authors:  D G Altman; K F Schulz; D Moher; M Egger; F Davidoff; D Elbourne; P C Gøtzsche; T Lang
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

Review 2.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

3.  The case for structuring the discussion of scientific papers.

Authors:  M Docherty; R Smith
Journal:  BMJ       Date:  1999-05-08

4.  How well is the clinical importance of study results reported? An assessment of randomized controlled trials.

Authors:  K B Chan; M Man-Son-Hing; F J Molnar; A Laupacis
Journal:  CMAJ       Date:  2001-10-30       Impact factor: 8.262

5.  Discussion sections in reports of controlled trials published in general medical journals: islands in search of continents?

Authors:  M Clarke; I Chalmers
Journal:  JAMA       Date:  1998-07-15       Impact factor: 56.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.